Approval · Notice of Compliance 2453 · 2001
MANDELAMINE: Notice of Compliance 2453
Issued January 23, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2453
- Date
- January 23, 2001
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Urinary antibacterial
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MANDELAMINE | 00499013 | Cancelled Post Market |
Medicinal ingredients
- METHENAMINE MANDELATE 500 MG per TAB